Get the Stockscreener App
9.63
2.03%
-0.20
After Hours:
9.63
Allovir Inc Stock (ALVR) Latest News
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - ACCESS Newswire
ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
UPCOMING ALVR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of EMKR, CCRN, WMPN, ALVR to Act Now - GlobeNewswire Inc.
(ALVR) Technical Pivots with Risk Controls - Stock Traders Daily
AlloVir (NASDAQ:ALVR) Stock Price Up 0.5%Should You Buy? - MarketBeat
IMMINENT ALVR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc.ALVR - Business Wire
AlloVir (NASDAQ:ALVR) Stock Price Up 0.5% – Should You Buy? - Defense World
$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of OMIC, BERY, WMPN, ALVR to Act Now - The Malaysian Reserve
Allovir director Vikas Sinha sells $1,225 in stock - MSN
Allovir's chief accounting officer sells $342 in common stock - MSN
Allovir's general counsel sells $494 in stock - MSN
Allovir's general counsel sells $494 in stock By Investing.com - Investing.com South Africa
Allovir's chief accounting officer sells $342 in common stock By Investing.com - Investing.com South Africa
Allovir director Vikas Sinha sells $1,225 in stock By Investing.com - Investing.com Australia
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline - GuruFocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCYTH, ALVR, WMPN, OMC - Morningstar
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Inve - GuruFocus.com
AlloVir (NASDAQ:ALVR) Trading 8.2% HigherHere's What Happened - MarketBeat
The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024 - Marketscreener.com
AlloVir (NASDAQ:ALVR) Hits New 1-Year LowWhat's Next? - MarketBeat
SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options - Marketscreener.com
Shareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Marketscreener.com
AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc - Marketscreener.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir - Marketscreener.com
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. LawsuitALVR - Marketscreener.com
Jane Street Group LLC Sells 89,680 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World
AlloVir executes reverse stock split By Investing.com - Investing.com Australia
AlloVir executes reverse stock split - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Allovir's general counsel Edward Miller sells $180 in stock - Investing.com India
Allovir stock plunges to 52-week low, touches $0.4 By Investing.com - Investing.com Canada
Allovir’s Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Nigeria
Allovir's Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Australia
Allovir’s general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Nigeria
Allovir’s chief accounting officer sells $146 in common stock By Investing.com - Investing.com Nigeria
Allovir's chief accounting officer sells $146 in common stock By Investing.com - Investing.com Australia
Allovir's general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Australia
Allovir's chief accounting officer sells $146 in common stock - Investing.com India
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):